PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 146 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $68,000 | -66.8% | 17,931 | -59.4% | 0.00% | -50.0% |
| Q1 2019 | $205,000 | +272.7% | 44,136 | +239.7% | 0.00% | – |
| Q4 2018 | $55,000 | -48.6% | 12,992 | -10.6% | 0.00% | -100.0% |
| Q3 2017 | $107,000 | +50.7% | 14,530 | +38.7% | 0.00% | 0.0% |
| Q2 2017 | $71,000 | -69.5% | 10,473 | -61.1% | 0.00% | -50.0% |
| Q4 2016 | $233,000 | +150.5% | 26,951 | +65.6% | 0.00% | +100.0% |
| Q3 2015 | $93,000 | -38.0% | 16,278 | -55.7% | 0.00% | 0.0% |
| Q1 2014 | $150,000 | +78.6% | 36,759 | +120.5% | 0.00% | – |
| Q3 2013 | $84,000 | – | 16,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 17,902,338 | $135,342,000 | 5.88% |
| TIGER MANAGEMENT L.L.C. | 1,288,454 | $9,741,000 | 1.91% |
| Phocas Financial Corp. | 1,047,181 | $7,917,000 | 0.69% |
| TUDOR INVESTMENT CORP ET AL | 2,370,503 | $17,921,000 | 0.62% |
| EAM Investors, LLC | 553,309 | $4,183,000 | 0.58% |
| Baker Brothers Advisors | 4,449,797 | $33,640,000 | 0.34% |
| TFS CAPITAL LLC | 463,740 | $3,506,000 | 0.33% |
| FEDERATED HERMES, INC. | 13,508,290 | $102,123,000 | 0.32% |
| Rotella Capital Management, Inc. | 36,473 | $276,000 | 0.24% |
| OXFORD ASSET MANAGEMENT LLP | 1,103,848 | $8,351,000 | 0.18% |